Kamla Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 30.00 Cr
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.00 Cr
- Revenue Growth -66.88%
- Profit Growth -145.79%
- Ebitda -112.66%
- Net Worth -22.98%
- Total Assets 8.59%
About Kamla Lifesciences
Kamla Lifesciences Limited (KLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 27 March 2012 and has a history of 12 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Kamla Lifesciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 30.00 Cr.
The company currently has active open charges totaling ₹42.00 Cr.
The Key Managerial Personnel (KMP) at Kamla Lifesciences Limited India are Leena Jain as COMPANY SECRETARY and Akash Lakhyani as Cfo. Digambar Zawar, Milind Save, Dilip Gupta, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233MH2012PLC228772
- Company No.
228772
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Kamla Lifesciences Limited offer?
Kamla Lifesciences Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Anesthetic, Pharma Ingredients & Raw Materials, Anti Infective API, Pain Reliever Gel.
Who are the key members and board of directors at Kamla Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Leena Jain | Company Secretary | 31-Mar-2023 | Current |
| Akash Lakhyani | CFO | 01-Jun-2022 | Current |
Digambar Zawar  | Managing Director | 27-Mar-2012 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Milind Save | Director | 04-Jan-2016 | Current |
| Dilip Gupta | Director | 19-Jun-2023 | Current |
| Rajendra Zawar | Director | 27-Mar-2012 | Current |
| Ketan Mistry | Director | 19-Jun-2023 | Current |
Financial Performance of Kamla Lifesciences.
Kamla Lifesciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 66.88% decrease. The company also saw a substantial fall in profitability, with a 145.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kamla Lifesciences?
In 2022, Kamla Lifesciences had a promoter holding of 93.80% and a public holding of 6.20%. The company had 2 Subsidiaries and 5 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Impulse Pharma Private LimitedDigambar Zawar and Rajendra Zawar are mutual person
Enicar Pharmaceuticals Private LimitedMilind Save is a mutual person
Kamla Films LlpDigambar Zawar is a mutual person
- Triokam Healthcare Llp
Digambar Zawar is a mutual person
- Kamford Healthcare Private Limited
Digambar Zawar and Rajendra Zawar are mutual person
- Conta Healthcare Private Limited
Digambar Zawar is a mutual person
Charges (Loans)
₹42.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 42.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2021 | Hdfc Bank Limited | ₹2.00 Cr | Open |
| 23 Aug 2019 | Hdfc Bank Limited | ₹5.00 Cr | Open |
| 23 Aug 2019 | Hdfc Bank Limited | ₹15.00 Cr | Open |
| 09 Aug 2019 | Hdfc Bank Limited | ₹20.00 Cr | Open |
How Many Employees Work at Kamla Lifesciences?
Kamla Lifesciences has a workforce of 136 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kamla Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamla Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
